|
1
|
Renal function worsening due to a combination of fibrates and statins
|
Discontinue fibrates
|
|
2
|
Lithium intoxication and acute renal failure in patients orally administered lithium carbonate
|
Measure blood lithium concentration and discontinue lithium carbonate
|
|
3
|
Liver dysfunction because of phenytoin
|
Change to other anti-epileptic drugs
|
|
4
|
Hypoglycemia with oral diabetes drugs
|
Reduce dose of oral diabetes drugs
|
|
5
|
Pancytopenia after an increase in carbamazepine dosage
|
Discontinue carbamazepine
|
|
6
|
Bevacizumab administered to a patient with planned tooth extraction
|
Change to chemotherapy without bevacizumab
|
|
7
|
Start of chemotherapy for grade 4 neutropenic patients
|
Postpone chemotherapy
|
|
8
|
No blood test after chemotherapy (grade 4 neutropenia)
|
Recommend blood test
|
|
9
|
Onset of grade 2 peripheral neuropathy after chemotherapy
|
Begin adjuvant analgesics
|
|
10
|
Anaphylaxis by premedication at start of chemotherapy
|
Change premedication
|
|
11
|
Start of chemotherapy for patients untreated for HBV-DNA-positive conversion
|
Postpone chemotherapy and begin oral administration of entecavir
|
|
12
|
Start of chemotherapy for patients untreated for HBV-DNA detection
|
Begin oral administration of entecavir
|
